Sarepta Shares Fall After Anthem Blue Cross Finds Issue With Eteplirsen
October 07, 2016 at 11:23 AM EDT
Shares of Sarepta Therapeutics Inc (NASDAQ: SRPT) fell about 5 percent Friday after Anthem Blue Cross said the clinical benefit of ...